Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Olive Branch Pharmaceutical is a biotechnology company based in Shenzhen, China, specializing in the development of innovative vaccines and therapeutics using mRNA technology. The company focuses on addressing infectious diseases, with a primary emphasis on respiratory viruses such as SARS-CoV-2 and Respiratory Syncytial Virus (RSV). By leveraging its proprietary mRNA platform, Olive Branch aims to provide rapid-response solutions to global health challenges. Their pipeline includes mRNA vaccine candidates currently in various stages of clinical and preclinical development. The company is part of a growing ecosystem of Chinese biotech firms focused on localizing and advancing genomic medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olive Branch Pharmaceutical.